298 related articles for article (PubMed ID: 31589023)
1. Targeting Ligands Deliver Model Drug Cargo into the Central Nervous System along Autonomic Neurons.
Sellers DL; Tan JY; Pineda JMB; Peeler DJ; Porubsky VL; Olden BR; Salipante SJ; Pun SH
ACS Nano; 2019 Oct; 13(10):10961-10971. PubMed ID: 31589023
[TBL] [Abstract][Full Text] [Related]
2. Targeted axonal import (TAxI) peptide delivers functional proteins into spinal cord motor neurons after peripheral administration.
Sellers DL; Bergen JM; Johnson RN; Back H; Ravits JM; Horner PJ; Pun SH
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):2514-9. PubMed ID: 26888285
[TBL] [Abstract][Full Text] [Related]
3. BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS.
Peluffo H; Unzueta U; Negro-Demontel ML; Xu Z; Váquez E; Ferrer-Miralles N; Villaverde A
Biotechnol Adv; 2015; 33(2):277-87. PubMed ID: 25698504
[TBL] [Abstract][Full Text] [Related]
4. A TfR-Binding Cystine-Dense Peptide Promotes Blood-Brain Barrier Penetration of Bioactive Molecules.
Crook ZR; Girard E; Sevilla GP; Merrill M; Friend D; Rupert PB; Pakiam F; Nguyen E; Yin C; Ruff RO; Hopping G; Strand AD; Finton KAK; Coxon M; Mhyre AJ; Strong RK; Olson JM
J Mol Biol; 2020 Jun; 432(14):3989-4009. PubMed ID: 32304700
[TBL] [Abstract][Full Text] [Related]
5. Targeted drug delivery to central nervous system (CNS) for the treatment of neurodegenerative disorders: trends and advances.
Goyal K; Koul V; Singh Y; Anand A
Cent Nerv Syst Agents Med Chem; 2014; 14(1):43-59. PubMed ID: 25360772
[TBL] [Abstract][Full Text] [Related]
6. Quantification and localization of PEGylated polycyanoacrylate nanoparticles in brain and spinal cord during experimental allergic encephalomyelitis in the rat.
Calvo P; Gouritin B; Villarroya H; Eclancher F; Giannavola C; Klein C; Andreux JP; Couvreur P
Eur J Neurosci; 2002 Apr; 15(8):1317-26. PubMed ID: 11994126
[TBL] [Abstract][Full Text] [Related]
7. Peptide sequences mediating tropism to intact blood-brain barrier: an in vivo biodistribution study using phage display.
Smith MW; Al-Jayyoussi G; Gumbleton M
Peptides; 2012 Nov; 38(1):172-80. PubMed ID: 22955033
[TBL] [Abstract][Full Text] [Related]
8. CNS drug delivery: opioid peptides and the blood-brain barrier.
Witt KA; Davis TP
AAPS J; 2006 Feb; 8(1):E76-88. PubMed ID: 16584136
[TBL] [Abstract][Full Text] [Related]
9. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
Barchet TM; Amiji MM
Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
[TBL] [Abstract][Full Text] [Related]
10. A New Noncanonical Anionic Peptide That Translocates a Cellular Blood-Brain Barrier Model.
Neves-Coelho S; Eleutério RP; Enguita FJ; Neves V; Castanho MARB
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057814
[TBL] [Abstract][Full Text] [Related]
11. Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands.
Moreira R; Nóbrega C; de Almeida LP; Mendonça L
J Nanobiotechnology; 2024 May; 22(1):260. PubMed ID: 38760847
[TBL] [Abstract][Full Text] [Related]
12. Identification of a peptide that crosses the blood-cerebrospinal fluid barrier by phage display technology.
Yang X; Li Y; Zhu Z; Huang X; Wang T; Yuan J; Li J
Amino Acids; 2021 Aug; 53(8):1181-1186. PubMed ID: 34185171
[TBL] [Abstract][Full Text] [Related]
13. In Vivo Translation of Peptide-Targeted Drug Delivery Systems Discovered by Phage Display.
Newman MR; Benoit DSW
Bioconjug Chem; 2018 Jul; 29(7):2161-2169. PubMed ID: 29889510
[TBL] [Abstract][Full Text] [Related]
14. Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system.
Thom G; Hatcher J; Hearn A; Paterson J; Rodrigo N; Beljean A; Gurrell I; Webster C
MAbs; 2018; 10(2):304-314. PubMed ID: 29182455
[TBL] [Abstract][Full Text] [Related]
15. Targeting choroid plexus epithelia and ventricular ependyma for drug delivery to the central nervous system.
Gonzalez AM; Leadbeater WE; Burg M; Sims K; Terasaki T; Johanson CE; Stopa EG; Eliceiri BP; Baird A
BMC Neurosci; 2011 Jan; 12():4. PubMed ID: 21214926
[TBL] [Abstract][Full Text] [Related]
16. [Development of Noninvasive Drug Delivery Systems to the Brain for the Treatment of Brain/Central Nervous System Diseases].
Kanazawa T
Yakugaku Zasshi; 2018; 138(4):443-450. PubMed ID: 29607986
[TBL] [Abstract][Full Text] [Related]
17. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair.
Sharma A; Menon P; Muresanu DF; Ozkizilcik A; Tian ZR; Lafuente JV; Sharma HS
CNS Neurol Disord Drug Targets; 2016; 15(9):1092-1117. PubMed ID: 27538949
[TBL] [Abstract][Full Text] [Related]
18. Neurodegenerative diseases and effective drug delivery: A review of challenges and novel therapeutics.
Akhtar A; Andleeb A; Waris TS; Bazzar M; Moradi AR; Awan NR; Yar M
J Control Release; 2021 Feb; 330():1152-1167. PubMed ID: 33197487
[TBL] [Abstract][Full Text] [Related]
19. Systematic Evolution of Ligands by Exosome Enrichment: A Proof-of-Concept Study for Exosome-Based Targeting Peptide Screening.
Liu X; Yang X; Sun W; Wu Q; Song Y; Yuan L; Yang G
Adv Biosyst; 2019 Feb; 3(2):e1800275. PubMed ID: 32627374
[TBL] [Abstract][Full Text] [Related]
20. Targeting the choroid plexus-CSF-brain nexus using peptides identified by phage display.
Baird A; Eliceiri BP; Gonzalez AM; Johanson CE; Leadbeater W; Stopa EG
Methods Mol Biol; 2011; 686():483-98. PubMed ID: 21082389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
